Literature DB >> 33462452

Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.

Noella Lopes1, Claire McIntyre2, Stefania Martin3, Mathilde Raverdeau4, Bruno Silva-Santos1, Daniel J Pennington5, Lydia Lynch2,4, Nital Sumaria3, Ayano C Kohlgruber2, Gina J Fiala1, Leandro Z Agudelo6, Lydia Dyck4, Harry Kane2,4, Aaron Douglas4, Stephen Cunningham4, Hannah Prendeville4, Roisin Loftus4, Colleen Carmody2, Philippe Pierre7,8, Manolis Kellis6, Michael Brenner2, Rafael J Argüello7.   

Abstract

Metabolic programming controls immune cell lineages and functions, but little is known about γδ T cell metabolism. Here, we found that γδ T cell subsets making either interferon-γ (IFN-γ) or interleukin (IL)-17 have intrinsically distinct metabolic requirements. Whereas IFN-γ+ γδ T cells were almost exclusively dependent on glycolysis, IL-17+ γδ T cells strongly engaged oxidative metabolism, with increased mitochondrial mass and activity. These distinct metabolic signatures were surprisingly imprinted early during thymic development and were stably maintained in the periphery and within tumors. Moreover, pro-tumoral IL-17+ γδ T cells selectively showed high lipid uptake and intracellular lipid storage and were expanded in obesity and in tumors of obese mice. Conversely, glucose supplementation enhanced the antitumor functions of IFN-γ+ γδ T cells and reduced tumor growth upon adoptive transfer. These findings have important implications for the differentiation of effector γδ T cells and their manipulation in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33462452      PMCID: PMC7610600          DOI: 10.1038/s41590-020-00848-3

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  55 in total

Review 1.  γδ T cells: first line of defense and beyond.

Authors:  Yueh-hsiu Chien; Christina Meyer; Marc Bonneville
Journal:  Annu Rev Immunol       Date:  2014-01-02       Impact factor: 28.527

Review 2.  Metabolic pathways in T cell activation and lineage differentiation.

Authors:  Luís Almeida; Matthias Lochner; Luciana Berod; Tim Sparwasser
Journal:  Semin Immunol       Date:  2016-11-04       Impact factor: 11.130

Review 3.  Metabolic Instruction of Immunity.

Authors:  Michael D Buck; Ryan T Sowell; Susan M Kaech; Erika L Pearce
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

Review 4.  Unraveling the Complex Interplay Between T Cell Metabolism and Function.

Authors:  Ramon I Klein Geltink; Ryan L Kyle; Erika L Pearce
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

5.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

Review 6.  Metabolic interventions in the immune response to cancer.

Authors:  David O'Sullivan; David E Sanin; Edward J Pearce; Erika L Pearce
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

7.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

8.  Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells.

Authors:  Candace M Cham; Gregory Driessens; James P O'Keefe; Thomas F Gajewski
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

Review 9.  Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies.

Authors:  Zsolt Sebestyen; Immo Prinz; Julie Déchanet-Merville; Bruno Silva-Santos; Jurgen Kuball
Journal:  Nat Rev Drug Discov       Date:  2019-09-06       Impact factor: 84.694

Review 10.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

View more
  22 in total

1.  Discovering dominant tumor immune archetypes in a pan-cancer census.

Authors:  Alexis J Combes; Bushra Samad; Jessica Tsui; Nayvin W Chew; Peter Yan; Gabriella C Reeder; Divyashree Kushnoor; Alan Shen; Brittany Davidson; Andrea J Barczak; Michael Adkisson; Austin Edwards; Mohammad Naser; Kevin C Barry; Tristan Courau; Taymour Hammoudi; Rafael J Argüello; Arjun Arkal Rao; Adam B Olshen; Cathy Cai; Jenny Zhan; Katelyn C Davis; Robin K Kelley; Jocelyn S Chapman; Chloe E Atreya; Amar Patel; Adil I Daud; Patrick Ha; Aaron A Diaz; Johannes R Kratz; Eric A Collisson; Gabriela K Fragiadakis; David J Erle; Alexandre Boissonnas; Saurabh Asthana; Vincent Chan; Matthew F Krummel
Journal:  Cell       Date:  2021-12-27       Impact factor: 41.582

2.  TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets.

Authors:  Bernardo S Reis; Patrick W Darcy; Iasha Z Khan; Christine S Moon; Adam E Kornberg; Vanessa S Schneider; Yelina Alvarez; Olawale Eleso; Caixia Zhu; Marina Schernthanner; Ainsley Lockhart; Aubrey Reed; Juliana Bortolatto; Tiago B R Castro; Angelina M Bilate; Sergei Grivennikov; Arnold S Han; Daniel Mucida
Journal:  Science       Date:  2022-07-14       Impact factor: 63.714

3.  Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes.

Authors:  Xiaofeng Mu; Zheng Xiang; Yan Xu; Jing He; Jianwen Lu; Yuyuan Chen; Xiwei Wang; Chloe Ran Tu; Yanmei Zhang; Wenyue Zhang; Zhinan Yin; Wing-Hang Leung; Yu-Lung Lau; Yinping Liu; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2022-07-11       Impact factor: 22.096

Review 4.  Tumor immune microenvironment and systemic response in breast cancer.

Authors:  Kosuke Kawaguchi; Yurina Maeshima; Masakazu Toi
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

5.  Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.

Authors:  Xiaoping Yang; Pingfan Wu; Zirui Wang; Xiaolu Su; Zhiping Wu; Xueni Ma; Fanqi Wu; Dekui Zhang
Journal:  Mol Cell Biochem       Date:  2022-10-11       Impact factor: 3.842

Review 6.  γδ T Cells in Brain Homeostasis and Diseases.

Authors:  Jang Hyun Park; In Kang; Heung Kyu Lee
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 7.  Lipid metabolism in T cell signaling and function.

Authors:  Seon Ah Lim; Wei Su; Nicole M Chapman; Hongbo Chi
Journal:  Nat Chem Biol       Date:  2022-04-28       Impact factor: 16.174

Review 8.  Diet, lipids, and antitumor immunity.

Authors:  Hannah Prendeville; Lydia Lynch
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

Review 9.  Systems-based approaches to study immunometabolism.

Authors:  Vinee Purohit; Allon Wagner; Nir Yosef; Vijay K Kuchroo
Journal:  Cell Mol Immunol       Date:  2022-02-04       Impact factor: 22.096

10.  Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities.

Authors:  Elena Lo Presti; Francesco Dieli; Serena Meraviglia
Journal:  Vaccines (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.